2015
DOI: 10.1016/j.bone.2014.12.060
|View full text |Cite
|
Sign up to set email alerts
|

Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity – an in vitro mechanism study for preventing destructive repair of osteonecrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
13
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 36 publications
2
13
0
1
Order By: Relevance
“…We also observed that ONFH stimulated maturation, migration, adhesion, and pit formation (bone resorption) of osteoclasts. In many skeletal diseases including osteoporosis, osteoarthritis and osteonecrosis, osteoclast activities increase [4345], and our results accord with them. Furthermore, geometric inspection revealed that the samples in the osteonecrosis group exhibited a shorter height and width of the femoral head than the sham operated control group.…”
Section: Discussionsupporting
confidence: 87%
“…We also observed that ONFH stimulated maturation, migration, adhesion, and pit formation (bone resorption) of osteoclasts. In many skeletal diseases including osteoporosis, osteoarthritis and osteonecrosis, osteoclast activities increase [4345], and our results accord with them. Furthermore, geometric inspection revealed that the samples in the osteonecrosis group exhibited a shorter height and width of the femoral head than the sham operated control group.…”
Section: Discussionsupporting
confidence: 87%
“…(30,31) We hypothesize that blockade of aberrant VEGF-Src signaling can inhibit both the vascular component (as evidenced by persistent marrow edema) and the skeletal component (ie, persistent bone resorption) of the destructive repair, but preserve VEGF-induced neovascularization in SAON. (32) We aim to determine the role of VEGF in destructive repair by supplementing and neutralizing VEGF, respectively, and define the role of Src through blocking Src by means of in vivo gene knockdown technology-RNAi using siRNA (33) with and without supplement of VEGF in a rabbit SAON model. (30,34) …”
Section: Introductionmentioning
confidence: 99%
“…While the mechanisms orchestrating endothelial repair, particularly considering those of the BBB, are not entirely defined, some molecular effectors and interconnecting pathways have been identified in the literature for their demonstrated involvement in repair processes in various model systems. In particular, cellular Src kinase (c-Src), a ubiquitously expressed member of the Src family of non-receptor tyrosine kinases, has a defined role in endothelial cell regulation and repair, both in vitro and in vivo (Takenaga et al, 2009; Liu et al, 2010; Franco et al, 2013; Bai et al, 2014; Cao et al, 2015), the specifics of which are described below. Importantly, c-Src is involved in pathways linked to the activation of vascular endothelial growth factor receptor 2 (VEGFR2) and N-methyl D-aspartate receptor (NMDAR), both of which are expressed on human BMECs and with demonstrated roles in BBB regulation and integrity (Sharp et al, 2003, 2005; Andras et al, 2007; Holmes et al, 2007; Davis et al, 2010; Reijerkerk et al, 2010; Hudson et al, 2014; Chen et al, 2016; Fearnley et al, 2016).…”
mentioning
confidence: 99%
“…To further support the role of c-Src in BBB health and repair, it has been reported that inhibition of c-Src by siRNA limited permeability of human umbilical vein endothelial cells (HUVEC) exposed to vascular endothelial growth factor (VEGF, a known inducer of permeability of the BBB; Holmes et al, 2007; Davis et al, 2010; Hudson et al, 2014; Cao et al, 2015; Fearnley et al, 2016). In addition, chemical inhibition of c-Src with the inhibitor 1-(1,1-dimethylethyl)-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP1) accelerated healing of wounded HUVEC (Franco et al, 2013), in vitro .…”
mentioning
confidence: 99%
See 1 more Smart Citation